Evaluation of Ki-67 Proliferation and Apoptotic Index Before, During and After Neoadjuvant Chemotherapy for Primary Breast Cancer

Breast Cancer Research - United Kingdom
doi 10.1186/bcr1508
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Ki67 Measured After Neoadjuvant Chemotherapy for Primary Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2013English

Association of Ki-67 Expression and Response of Neoadjuvant Chemotherapy in Invasive Breast Cancer Patients in Bandung

International Journal of Integrated Health Sciences
2018English

Impact on Survival of Estrogen Receptor, Progesterone Receptor and Ki-67 Expression Discordance Pre- And Post-Neoadjuvant Chemotherapy in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

Fibulin-5 Downregulates Ki-67 and Inhibits Proliferation and Invasion of Breast Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2016English

Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity Before and After Neoadjuvant Chemotherapy

Cancers
Cancer ResearchOncology
2019English

Proliferative Activity in Human Breast Cancer: Ki-67 Automated Evaluation and the Influence of Different Ki-67 Equivalent Antibodies

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2011English

Patterns of Dual-Specific Phosphatase 4 mRNA Expression Before and After Neoadjuvant Chemotherapy in Breast Cancer

Asian Pacific Journal of Cancer Prevention
2019English

Effect of Embolisation of Meningioma on Ki-67 Proliferation Index.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1993English

O2-8-5Prognostic Value of Subtype Changes After Neoadjuvant Chemotherapy in Primary Breast Cancer

Annals of Oncology
MedicineOncologyHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy